These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 802473

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The role of anti-H-2K and H-2D alloantibodies in enhancement and acute antibody-mediated rejection of mouse skin allografts.
    de Waal RM, Capel PJ, Koene RA.
    J Immunol; 1980 Feb; 124(2):719-23. PubMed ID: 6985936
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Regulation of transplantation immunity in vivo by monoclonal antibodies recognizing host class II restriction elements. I. Genetics and specificity of anti-Ia immunotherapy in murine skin allograft recipients.
    Perry LL, Williams IR.
    J Immunol; 1985 May; 134(5):2935-41. PubMed ID: 2580008
    [Abstract] [Full Text] [Related]

  • 7. Passive enhancement of mouse skin allografts. Specificity of the antiserum for major histocompatibility.
    Staines NA, Guy K, Davies DA.
    Transplantation; 1974 Aug; 18(2):192-5. PubMed ID: 4602953
    [No Abstract] [Full Text] [Related]

  • 8. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.
    Tomita Y, Mayumi H, Eto M, Nomoto K.
    J Immunol; 1990 Mar 15; 144(6):2425-35. PubMed ID: 1968930
    [Abstract] [Full Text] [Related]

  • 9. Prolongation of murine skin allograft survival by immunologic manipulation with anti-interleukin 2 receptor antibody.
    Granstein RD, Goulston C, Gaulton GN.
    J Immunol; 1986 Feb 01; 136(3):898-902. PubMed ID: 3079802
    [Abstract] [Full Text] [Related]

  • 10. Hyperacute rejection and enhancement of mouse skin grafts by antibodies with a distinct specificity.
    Jansen JL, Koene RA, Kamp GJ, Hagemann JF, Wijdeveld PG.
    J Immunol; 1975 Aug 01; 115(2):392-4. PubMed ID: 1097512
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. In vivo activity of an H-2 alloantiserum purified by affinity chromatography on transplantation antigens.
    de Waal RM, Lems SP, Koene RA.
    Transplantation; 1979 Jun 01; 27(6):376-9. PubMed ID: 380077
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Mechanism of passive enhancement].
    Soulillou JP, d'Apice AF.
    Biomedicine; 1977 Apr 01; 26(2):79-85. PubMed ID: 301409
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Reduced diversity of CTLs specific for multiple minor histocompatibility antigens relative to allograft rejection in vivo.
    Nevala WK, Paul C, Wettstein PJ.
    J Immunol; 1997 Feb 01; 158(3):1102-7. PubMed ID: 9013948
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.